|
0
|
|
Lactylated NAT10 contributes to elesclomol-triggered cuproptosis via the NAT10/ac4C-DLAT-mRNA/DLAT positive feedback loop in CRC.
(pnas.org)
|
Yang WD
…
Bai J
PNAS
2026-05-12
|
#metabolism
#cancer
#cuproptosis
#ptm
|
|
0
|
|
Functional dissection of SPOP at the amino acid level reveals a comprehensive functional landscape of variants during tumorigenesis.
(pnas.org)
|
Park SK
…
Choi M
PNAS
2026-05-12
|
#cancer
#sequencing
#mutagenesis
#protein function
|
|
0
|
|
A ginsenoside metabolite and its derivative target PRELID3B against lung cancer cells.
(pnas.org)
|
He J
…
Che CM
PNAS
2026-05-12
|
#proteomics
#metabolism
#cancer
#immunomodulation
|
|
0
|
|
Metatranscriptomic analysis of the microbiota of tumor tissue in colon cancer.
(link.springer.com)
|
Buetas E
…
Mira A
Microbiome
2026-05-12
|
#microbiome
#metabolism
#dysbiosis
#cancer
#metatranscriptomics
|
|
0
|
|
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcome.
(gut.bmj.com)
|
Milardi G
…
Lleo A
Gut
2026-05-12
|
#immunosuppression
#immunity
#cancer
#microenvironment
#chemoimmunotherapy
|
|
0
|
|
Nicotinamide attenuates the virulence of colorectal cancer-associated Fusobacterium nucleatum.
(journals.asm.org)
|
Yang Z
…
Li Y
Infection and Immunity
2026-05-12
|
#virulence
#transcriptomics
#cancer
#biofilm
#pathogenicity
|
|
0
|
|
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy.
(gut.bmj.com)
|
Liu J
…
Hao J
Gut
2026-05-12
|
#cancer
#glycosylation
#mutation
#organoid
#therapeutic resistance
|
|
0
|
|
Regulation of antiviral and antitumor immunity by the BRCA1 pseudogene in human cancers.
(pnas.org)
|
Han YJ
…
Olopade OI
PNAS
2026-05-12
|
#immunity
#cancer
#inflammation
#apoptosis
|
|
0
|
|
Cancer epitope prediction tools and analysis pipelines in CEDAR.
(academic.oup.com)
|
Carri I
…
Kosaloglu-Yalcin Z
Nucleic Acids Research
2026-05-12
|
#immunity
#cancer
#immunotherapy
#prediction
#epitope
|
|
0
|
|
MiR-155-driven loss of ICOSL and SOCS1 in EBV+ gastric cancers renders abundant cytotoxic T cells ineffective, enabling immune evasion.
(pnas.org)
|
Nuovo GJ
…
Croce CM
PNAS
2026-05-12
|
#infection
#immunity
#cancer
#microrna
#immune evasion
|
|
0
|
|
MEK interactions tune RAF kinase sensitivity to conformation-selective inhibition.
(nature.com)
|
Stoddard EG
…
Maly DJ
Nature Chemical Biology
2026-05-12
|
#cancer
#therapeutics
#signaling
#kinase
#inhibitor
|